Skip to content

To Compare the efficacy Varma manipulation with Murivukku choornam (internal) and Murivu Ennai II (External) in the Treatment of Muzhankaal Muttu Savvu Kaayam

An open labelled double arm non randomized phase II clinical trial To Compare the efficacy Varma manipulation with Murivukku choornam (internal) and Murivu Ennai II (External) in the Treatment of Muzhankaal Muttu Savvu Kaayam

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031389
Enrollment
20
Registered
2021-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

Intervention1: Varma and mudivu Ennai II: Varma manipulation and oil application for 48 days Control Intervention1: Murivuku choornam and mudivu Ennai II: 800-1000mg/BD/After food and external applica

Sponsors

Government Siddha Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pain tenderness acute and severe in knee joints Pain get worse while working Swelling present in knee joint Feeling if looseness in knee joint Patient willing to undergo radiological and laboratory investigations Patient willing to sign the informed consent stating that he or she will continuously stick to the treatment during 48 days but can opt out of the trial of his or her own conscious discretion

Exclusion criteria

Exclusion criteria: Complete ligament tear of the knee joint Posterior cruciate ligament tear Evidence of bony fractures in X-rays H/o Cardiac diseases H/o Diabetes mellitus H/o Rheumatoid arthritis H/o Chronic kidney disease Pregnancy and lactation Septic arthritis Gonococcal arthritis Psoriatic arthritis Patient with any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
The study is pain relieving and it will be assessed by the method Koos knee surveyTimepoint: 48 days

Secondary

MeasureTime frame
Assessment of quality of life by EQ-5D Assessment of safety parametersTimepoint: 48 days

Countries

India

Contacts

Public ContactDr A Muneeswaran

Government Siddha medical college and Hospital

ameswar1968@gmail.com9443724897

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026